Treatment of sphingomyelinase deficiency by repeated implantations of amniotic epithelial cells.
Five young patients with Niemann-Pick disease type B were treated with repeated implantations of amniotic epithelial cells, as a source of exogenous sphingomyelinase. This treatment abolished the recurrent infections, mainly of the respiratory tract, and led to other improvements of the general conditions of the patients. In particular, we noticed a disappearance of vomiting, a recovery from muscular hypotrophy, and significantly reduced pulmonary distress. In four subjects, who were in a prepuberal state, there was a puberal spurt with a concomitant burst of growth. In two cases, characterized by a greater than normal content of sphingomyelin in urinary sediments, a single implantation caused a sustained normalization of sphingomyelin and total phospholipids in the urine. Finally, sphingomyelinase activity of peripheral leukocytes, when assayed 0.5 to 4 months after some of the implantations, showed a rise to heterozygous values in 30-40% of the assays.
Bembi
B
B
Children's Hospital Burlo Garofolo, University of Trieste, Italy.
Comelli
M
M
Scaggiante
B
B
Pineschi
A
A
Rapelli
S
S
Gornati
R
R
Montorfano
G
G
Berra
B
B
Agosti
E
E
Romeo
D
D
D000293:Adolescent; D000650:Amnion / Q000637:transplantation*; D002478:Cells, Cultured; D002648:Child; D004848:Epithelium / Q000637:transplantation; D005260:Female; D006801:Humans; D007962:Leukocytes / Q000201:enzymology; D008297:Male; D009542:Niemann-Pick Diseases / Q000628:therapy*; D010743:Phospholipids / Q000652:urine; D013108:Sphingomyelin Phosphodiesterase / Q000172:deficiency*
D010743:Phospholipids; D013108:Sphingomyelin Phosphodiesterase